Literature DB >> 25236844

Estimating danofloxacin withdrawal time in broiler chickens based on physiologically based pharmacokinetics modeling.

F Yang1, N Sun, Y M Liu, Z L Zeng.   

Abstract

In this study, a physiologically based pharmacokinetics (PBPK) model was firstly developed for danofloxacin in healthy broiler chickens after a single oral administration at 5 mg/kg bw. Then, the model extrapolation from healthy chickens to those infected with Pasteurella multocidaones was performed. The healthy model was validated through a comparison of predicted and previously published concentrations, which indicated that the healthy PBPK model had good predictive ability in plasma, lung, muscle, liver, and kidney, especially at the later sampling time points. Multiple dosing of administration was incorporated into the healthy and infected models. In addition, a Monte Carlo simulation (MCS) included 1000 iterations was further incorporated into both models to predict the withdrawal times of danofloxacin in healthy and infected chickens, which were estimated to be 3 and 2 days, respectively.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25236844     DOI: 10.1111/jvp.12162

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  5 in total

1.  Disposition kinetics of orbifloxacin in tissues of crucian carp (Carassius auratus) following a single intramuscular administration.

Authors:  Y R Yang; F Yang; N Sun; G Y Wang
Journal:  Iran J Vet Res       Date:  2019       Impact factor: 1.376

2.  Development and Application of a Water Temperature Related Physiologically Based Pharmacokinetic Model for Enrofloxacin and Its Metabolite Ciprofloxacin in Rainbow Trout.

Authors:  Fan Yang; Fang Yang; Dan Wang; Chao-Shuo Zhang; Han Wang; Zhe-Wen Song; Hao-Tian Shao; Mei Zhang; Meng-Li Yu; Yang Zheng
Journal:  Front Vet Sci       Date:  2021-01-25

3.  Quantitative Comparison of Avian and Mammalian Physiologies for Parameterization of Physiologically Based Kinetic Models.

Authors:  Colin G Scanes; Johannes Witt; Markus Ebeling; Stephan Schaller; Vanessa Baier; Audrey J Bone; Thomas G Preuss; David Heckmann
Journal:  Front Physiol       Date:  2022-04-05       Impact factor: 4.755

4.  In Vivo Pharmacokinetic/Pharmacodynamic Profiles of Danofloxacin in Rabbits Infected With Salmonella typhimurium After Oral Administration.

Authors:  Xia Xiao; Lin Pei; Li-Jie Jiang; Wei-Xuan Lan; Jia-Yu Xiao; Yon-Jia Jiang; Zhi-Qiang Wang
Journal:  Front Pharmacol       Date:  2018-04-17       Impact factor: 5.810

5.  A comparative pharmacokinetic study of a novel sustained release danofloxacin formulation and the conventional product in rabbits.

Authors:  Ali Rassouli; Katayoun Kiani; Yalda Hosseinzadeh Ardakani; Hamid Akbari Javar; Sakineh Khanamani Falahatipour
Journal:  Vet Res Forum       Date:  2021-06-15       Impact factor: 1.054

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.